Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-02

Clinical Trial Update: Tortle Midliner and Intraventricular Hemorrhage [NA]

View source ↗

Summary

Clinical trial update for Tortle Midliner in intraventricular hemorrhage of prematurity; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tortle Midliner

Snippet

Sponsor: Orlando Health, Inc. | Conditions: Intraventricular Hemorrhage of Prematurity | NA | Status: TERMINATED | Results posted: 2022-06-02